Chase AIPricingFAQs
Display currency
Loading news…

Vincere Biosciences

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Cambridge, Massachusetts, United States Founded 2018 1-10 employees For Profit

Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
4
Patents
4

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
34
Patents granted
4
Trademarks
0
Top patent class
Organic Chemistry
IT spend
$280K

Company Info

Founded
2018
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
8
HQ
Cambridge, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
0.8
Trend (30d)
-0.3
Trend (90d)
-0.4

Key People at Vincere Biosciences

COO
4
professional contacts at Vincere Biosciences
Contact execs at Vincere Biosciences

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Vincere Biosciences

Loading news…

FAQs about Vincere Biosciences

People who checked this page also checked these

Browse the full Acquirezy directory.
Vincere Biosciences - Company Profile, Full Acquisitions List, Funding and Investments